These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7151293)

  • 21. Tracer kinetic studies of glucose and alanine metabolism in diabetic dogs on the artificial beta cell.
    Freyse EJ; Fischer U; Albrecht G
    Biomed Biochim Acta; 1984; 43(5):607-14. PubMed ID: 6477544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Use of the endocrine artificial pancreas (GCIIS; Biostator) in heart surgery].
    Calabrese G; Bueti A; Zega G; Bellomo G; Antonella MA; Giombolini A; Tardioli F; Massi-Benedetti M; Palminiello A
    Minerva Med; 1982 Dec; 73(49-50):3509-14. PubMed ID: 7155400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Various biohumoral parameters (blood triglycerides, blood cholesterol, blood uric acid, blood electrolytes) after automatic control by an artificial pancreas in subjects with type I diabetes mellitus].
    Sinagra D; Amato MP; Cangemi C; La Sala MS
    Boll Soc Ital Biol Sper; 1984 Sep; 60(9):1691-5. PubMed ID: 6525287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The development of a needle-type glucose sensor for wearable artificial endocrine pancreas.
    Yamasaki Y
    Med J Osaka Univ; 1984 Sep; 35(1-2):25-34. PubMed ID: 6527668
    [No Abstract]   [Full Text] [Related]  

  • 25. Artificial connection between glucose sensing and insulin delivery: implications of peritoneal administration.
    Fischer U; Freyse EJ; Salzsieder E; Rebrin K
    Artif Organs; 1992 Apr; 16(2):151-62. PubMed ID: 10078237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intensified insulin regimens. Should they be used in all patients with type I diabetes?
    Hollander P
    Postgrad Med; 1994 Sep; 96(3):63-8, 72. PubMed ID: 8072915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetes: controlling the insulin balance. Tight control: what does it mean.
    Bates S; Ahern JA
    Am J Nurs; 1986 Nov; 86(11):1256-8. PubMed ID: 3535512
    [No Abstract]   [Full Text] [Related]  

  • 28. Neural network modeling and control of type 1 diabetes mellitus.
    El-Jabali AK
    Bioprocess Biosyst Eng; 2005 Apr; 27(2):75-9. PubMed ID: 15578231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Automated feedback control of subcutaneous glucose concentration in diabetic dogs.
    Rebrin K; Fischer U; von Woedtke T; Abel P; Brunstein E
    Diabetologia; 1989 Aug; 32(8):573-6. PubMed ID: 2673892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Closed-loop subcutaneous insulin infusion algorithm with a short-acting insulin analog for long-term clinical application of a wearable artificial endocrine pancreas.
    Shimoda S; Nishida K; Sakakida M; Konno Y; Ichinose K; Uehara M; Nowak T; Shichiri M
    Front Med Biol Eng; 1997; 8(3):197-211. PubMed ID: 9444512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucose monitoring and pump data management software operated on a personal digital assistant can contribute to improve diabetes control in CSII-treated patients.
    Boizel R; Benhamou PY; Renard E;
    Diabetes Metab; 2007 Sep; 33(4):314-5. PubMed ID: 17475533
    [No Abstract]   [Full Text] [Related]  

  • 32. The artificial pancreas: current status and future prospects in the management of diabetes.
    Peyser T; Dassau E; Breton M; Skyler JS
    Ann N Y Acad Sci; 2014 Apr; 1311():102-23. PubMed ID: 24725149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Intensified insulin therapy in Type-I diabetes].
    Keller U; Straumann E; Berger W
    Schweiz Rundsch Med Prax; 1988 Mar; 77(9):213-7. PubMed ID: 3283907
    [No Abstract]   [Full Text] [Related]  

  • 34. [The insulin pump in type II diabetics].
    Svacina S; Masek Z; Páv J; Kábrt J; Hovorka R; Ponka J
    Vnitr Lek; 1988 Feb; 34(2):146-52. PubMed ID: 3284182
    [No Abstract]   [Full Text] [Related]  

  • 35. [The importance of strict control of blood glucose at the onset and during the remission stage in newly diagnosed diabetic children].
    Vavrinec J; Lébl J; Zizkovský V; Dvorák P; Snajderová M
    Cesk Pediatr; 1988 May; 43(5):325-8. PubMed ID: 3042170
    [No Abstract]   [Full Text] [Related]  

  • 36. [Unstable type I diabetes mellitus: comparative study between intensive conventional treatment and continuous subcutaneous infusion of insulin].
    Levy I; Bergua M; Esmatjes E; Halperin I; Figuerola D
    Med Clin (Barc); 1984 Oct; 83(13):525-8. PubMed ID: 6392766
    [No Abstract]   [Full Text] [Related]  

  • 37. Preprandial and postprandial variations of insulin sensitivity in different times of the day assessed by the artificial pancreas in type I diabetics.
    Trovati M; Bruno A; Lorenzati R; Caselle MT; Pagani A; Gorzegno G; Pagano G
    Chronobiologia; 1981; 8(4):333-40. PubMed ID: 7035094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Insulin needs of insulin-dependent diabetics during biostator control and subcutaneous use of insulin].
    Petkova M; Khristov V; Tsanev A
    Vutr Boles; 1990; 29(1):74-7. PubMed ID: 2204207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of diabetics using portable insulin pumps].
    Vavrinec J; Kopecký A; Zizkovský V; Lebl J; Sturmová M
    Cesk Pediatr; 1985 Dec; 40(12):701-4. PubMed ID: 4085018
    [No Abstract]   [Full Text] [Related]  

  • 40. [Use of the Biostator in optimizing insulin treatment (preliminary communication)].
    Kábrt J; Masek Z; Páv J
    Vnitr Lek; 1985 Sep; 31(9):870-6. PubMed ID: 4049764
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.